Related Experiment Video
Updated: Dec 6, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Less is more: critically ill status is not a carte blanche for unlimited antibiotic use
Andre C Kalil1, Jean-Francois Timsit2,3
1Department of Internal Medicine, Division of Infectious Disease, University of Nebraska Medical Center, Omaha, NE, USA. akalil@unmc.edu.
No abstract available in PubMed .
More Related Videos
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Antibiotic Selection
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care